| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2022 | AHCO Adapthealth Corp. | Everest Hill Group Inc.86 | 10% Owner | Sell | 900,000 | $19.53 | $17,580,000.00 | -1.2% | +1.4% | -55.3% | |
| Sep 22, 2022 | SMTI Sanara Medtech Inc. | Bowman Shawn M. | Pres. - Strategic Partnerships | Sell | 1,000 | $27.89 | $27,886.80 | -2.6% | +40.3% | +15.5% | |
| Sep 22, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 6,754 | $77.00 | $520,058.00 | -9.6% | +4.9% | -76.9% | |
| Sep 22, 2022 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $84.17 | $1,672,838.75 | -3.6% | -11.2% | -17.2% | |
| Sep 22, 2022 | EKSO Ekso Bionics Holdings, Inc. | Sherman Steven72 | CEO &Chairman | Sell | 6,043 | $1.75 | $10,552.89 | -0.9% | -29.7% | -59.9% | |
| Sep 21, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 3,683 | $3.89 | $14,326.87 | -0.3% | -51.3% | -80.6% | |
| Sep 21, 2022 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 984 | $3.89 | $3,827.76 | -0.3% | -51.3% | -80.6% | |
| Sep 21, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 973 | $3.89 | $3,784.97 | -0.3% | -51.3% | -80.6% | |
| Sep 21, 2022 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 2,946 | $3.89 | $11,459.94 | -0.3% | -51.3% | -80.6% | |
| Sep 20, 2022 | LUCD Lucid Diagnostics Inc. | Lapidus Stanley74 | Director | Sell | 33,864 | $1.70 | $57,682.70 | -10.5% | -8.1% | -16.2% | |
| Sep 19, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 18,000 | $8.09 | $145,584.00 | +0.9% | +20.2% | +0.6% | |
| Sep 19, 2022 | BFLY Butterfly Network, Inc. | Shahida Darius76 | Chief Strategy/ Bus Dev Officer | Sell | 20,139 | $5.49 | $110,629.57 | -3.0% | -59.0% | -74.9% | |
| Sep 19, 2022 | HAE Haemonetics Corp | Miller Laurie A. | SVP, Human Resources | Sell | 212 | $76.25 | $16,165.00 | -1.6% | +1.9% | +16.7% | |
| Sep 19, 2022 | HAE Haemonetics Corp | Basil Michelle L51 | EVP And General Counsel | Sell | 11,448 | $78.36 | $897,065.28 | -26.0% | +1.9% | +16.7% | |
| Sep 19, 2022 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $12.42 | $248,400.00 | -0.2% | -17.6% | -49.2% | |
| Sep 16, 2022 | NXL Nexalin Technology, Inc. | White Mark | President/ CEO | Buy | 2,500 | $4.15 | $10,375.00 | +0.9% | -29.0% | -71.3% | |
| Sep 16, 2022 | NXL Nexalin Technology, Inc. | Morad Rick | Director | Buy | 2,500 | $4.15 | $10,375.00 | +2.4% | -29.0% | -71.3% | |
| Sep 16, 2022 | VERO Venus Concept Inc. | Della Penna Domenic | Chief Financial Officer | Buy | 60,000 | $0.59 | $35,403.00 | +36.7% | -54.7% | -78.0% | |
| Sep 16, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 12,500 | $3.81 | $47,662.50 | -1.0% | -45.7% | -80.1% | |
| Sep 16, 2022 | NXL Nexalin Technology, Inc. | Elson Marilyn | Ms. Elson Serves As CFO | Buy | 36,000 | $4.15 | $149,400.00 | +4.6% | -29.0% | -71.3% | |
| Sep 16, 2022 | NXL Nexalin Technology, Inc. | Owens David | Chief Medical Officer | Buy | 2,500 | $4.15 | $10,375.00 | +1.8% | -29.0% | -71.3% | |
| Sep 16, 2022 | NXL Nexalin Technology, Inc. | Kazden Alan | Director | Buy | 2,500 | $4.15 | $10,375.00 | +2.9% | -29.0% | -71.3% | |
| Sep 16, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 6,530 | $8.09 | $52,852.91 | +0.2% | +28.5% | +7.6% | |
| Sep 15, 2022 | CNMD Conmed Corp | Hartman Curt R66 | President, CEO And Chair | Sell | 3,500 | $93.94 | $328,776.00 | -25.4% | +0.6% | +16.5% | |
| Sep 15, 2022 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 25,000 | $20.00 | $500,000.00 | -2.4% | -65.4% | -47.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.